Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. 19638620 Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY, Baris D, Conde B, Rothman N Blood 2009 PLCO
A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. 19124507 Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
B-cell clones as early markers for chronic lymphocytic leukemia. 19213679 Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE N. Engl. J. Med. 2009 PLCO
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. 19208842 Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT Cancer Res. 2009 PLCO
A multicenter study of prevalence and risk factors for aberrant crypt foci. 19418605 Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D, Charabaty A, Chia D, Umar A, Viner J, Hawk E, Pinsky PF Clin. Gastroenterol. Hepatol. 2009 PLCO
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. 19493248 Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB, Savage SA Aging Cell 2009 PLCO
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 19258472 Grubb RL, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL, PLCO Project Team Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. 19549809 Lu L, Sun J, Isaacs SD, Wiley KE, Smith S, Pruett K, Zhu Y, Zhang Z, Wiklund F, Grönberg H, Walsh PC, Chang BL, Zheng SL, Isaacs WB, Xu J Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustment. 19140130 Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Thomas G, Yu K Genet. Epidemiol. 2009 PLCO
Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. 19067193 Berndt SI, Huang WY, Yeager M, Weissfeld JL, Chanock SJ, Hayes RB Cancer Causes Control 2009 PLCO
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. 19561064 Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Amundadottir L, Bingham SA, Boffetta P, Boutron-Ruault MC, Chanock SJ,… Am. J. Epidemiol. 2009 PLCO
Airway wall attenuation: a biomarker of airway disease in subjects with COPD. 19407254 Washko GR, Dransfield MT, Estépar RS, Diaz A, Matsuoka S, Yamashiro T, Hatabu H, Silverman EK, Bailey WC, Reilly JJ J. Appl. Physiol. 2009 NLST
Estimation of absolute risk for prostate cancer using genetic markers and family history. 19562736 Xu J, Sun J, Kader AK, Lindström S, Wiklund F, Hsu FC, Johansson JE, Zheng SL, Thomas G, Hayes RB, Kraft P, Hunter DJ, Chanock SJ, Isaacs WB, Grönberg H Prostate 2009 PLCO
Results from four rounds of ovarian cancer screening in a randomized trial. 19305319 Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, Kessel B, Johnson CC, Weissfeld JL, Isaacs C, Andriole GL, Ogden S, Ragard LR, Buys SS, PLCO Project Team Obstet Gynecol 2009 PLCO
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). 19330030 Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, Hankinson SE, Hutchinson A, Wang Z, Yu K, Chatterjee N, Garcia-Closas M, Gonzalez-Bosquet J, Prokunina-Olsson L, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Fe… Nat. Genet. 2009 PLCO
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 19183461 Azzato EM, Morton LM, Bergen AW, Wang SS, Chatterjee N, Kvale P, Yeager M, Hayes RB, Chanock SJ, Caporaso NE BMC Med. Genet. 2009 PLCO
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. 19336558 Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, Peters U Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. 19648918 Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clave… Nat. Genet. 2009 PLCO
Mortality results from a randomized prostate-cancer screening trial. 19297565 Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohag… N. Engl. J. Med. 2009 PLCO
Nitric oxide synthase gene polymorphisms and prostate cancer risk. 19168583 Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, Chanock S, Huang WY, Hayes RB Carcinogenesis 2009 PLCO